Arteris (NASDAQ:AIP) Sets New 12-Month High – Should You Buy?

Arteris, Inc. (NASDAQ:AIP)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $32.27 and last traded at $31.8150, with a volume of 56244 shares traded. The stock had previously closed at $31.86.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris posted a smaller-than-expected Q1 loss of $0.03 per share, beating the consensus loss estimate of $0.08 and improving from a $0.09 loss a year ago. Article Title
• Positive Sentiment: Revenue came in at $22.94 million, ahead of the $21.03 million estimate, showing stronger-than-expected demand and execution. Article Title
• Positive Sentiment: Management raised second-quarter and full-year revenue guidance, with Q2 sales expected at $23.0 million-$24.0 million and FY2026 revenue projected at $91.0 million-$95.0 million, both at or above analyst expectations. Article Title
• Neutral Sentiment: The company also released its earnings call transcript and investor materials, which may provide additional detail on growth drivers, margins, and customer momentum. Article Title

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on AIP shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research report on Monday, April 20th. Wall Street Zen cut shares of Arteris from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Rosenblatt Securities reissued a “buy” rating and issued a $20.00 price target on shares of Arteris in a research report on Friday, February 13th. Northland Securities set a $24.00 price target on shares of Arteris in a research report on Friday, February 13th. Finally, Jefferies Financial Group reissued a “hold” rating on shares of Arteris in a research report on Wednesday. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Arteris currently has a consensus rating of “Hold” and a consensus target price of $20.17.

Arteris Stock Down 2.1%

The stock has a market capitalization of $1.49 billion, a PE ratio of -39.55 and a beta of 1.93. The business’s 50-day moving average is $20.37 and its two-hundred day moving average is $17.15.

Arteris (NASDAQ:AIP) last announced its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $20.14 million during the quarter, compared to analysts’ expectations of $18.55 million. As a group, analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current year.

Insider Buying and Selling at Arteris

In other Arteris news, Director Saiyed Atiq Raza sold 106,031 shares of Arteris stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $17.21, for a total value of $1,824,793.51. Following the transaction, the director directly owned 393,690 shares in the company, valued at approximately $6,775,404.90. The trade was a 21.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO K Charles Janac sold 70,000 shares of Arteris stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $19.04, for a total transaction of $1,332,800.00. Following the completion of the transaction, the chief executive officer owned 9,119,071 shares in the company, valued at approximately $173,627,111.84. This represents a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 866,923 shares of company stock worth $18,543,293. 33.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AIP. Roubaix Capital LLC acquired a new position in shares of Arteris during the third quarter worth about $2,361,000. Herald Investment Management Ltd increased its stake in shares of Arteris by 33.3% during the third quarter. Herald Investment Management Ltd now owns 400,000 shares of the company’s stock worth $4,036,000 after acquiring an additional 100,000 shares during the period. Granahan Investment Management LLC increased its stake in shares of Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after acquiring an additional 546,341 shares during the period. GSA Capital Partners LLP increased its stake in shares of Arteris by 59.3% during the third quarter. GSA Capital Partners LLP now owns 132,079 shares of the company’s stock worth $1,334,000 after acquiring an additional 49,153 shares during the period. Finally, Huntleigh Advisors Inc. acquired a new position in shares of Arteris during the fourth quarter worth about $1,832,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.